The frequency of CD352+CD39+ T cells and CD352-CD8+ T cells was notably higher in tumor tissues, followed by peri-tumor tissues, while the lowest expression frequency was observed in the peripheral blood PBMCs of tumor patients. This evidence concerns the gene CD8A and neoplasm.